Investor reminder: berger montague notifies regeneron pharmaceuticals, inc. (nasdaq: regn) investors of a class action lawsuit and deadline

Philadelphia, jan. 21, 2025 (globe newswire) -- a securities class action lawsuit has been filed against regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn). the lawsuit has been filed on behalf of purchasers of regeneron securities between november 2, 2023 and october 30, 2024, inclusive (the “class period”).
REGN Ratings Summary
REGN Quant Ranking